New bone graft aims to cut repeat surgeries in spine deformity patients

NCT ID NCT05038527

Completed Disease control Sponsor: Rigshospitalet, Denmark Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compared a new bone graft material (ABM/P-15) to the standard bone graft in 120 adults having surgery for spinal deformity. The goal was to see if the new graft leads to fewer additional surgeries and better bone healing. Patients were randomly assigned to receive either the new or standard graft, and results were tracked over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: ABM/P-15 bone graft (anorganic bovine bone mineral coated with a bioactive peptide)
What this could lead to: If it works, this could mean fewer repeat surgeries and faster bone healing for adults undergoing spinal deformity surgery.
What could go wrong: This is a single, completed trial with 120 patients, so results may not apply to everyone. The new graft might not be better than the standard approach.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVERSE EVENTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

vertebral column disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADVERSE EVENTS BONE GRAFT; COMPLICATIONS SPINE DEFORMITY

Contacts and locations

Locations

Rigshospitalet, Department of Orthopedics, Spine Unit

Copenhagen, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.